Zhiyong Peng - Concepedia

Author

Zhiyong Peng

Zhongnan Hospital of Wuhan University ORCID

Also Known As

Huaying Liu, Peng, Zhiyong, Yongchareon, Sira, Yoo, Jaesoo, Z Peng, Z. Peng, Z.G. Peng, Zelong Peng, Zhenzhen Peng, Zhi-Yong Peng

128

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Zhongnan Hospital of Wuhan University Wuhan University Southern Medical University Fudan University Zhongshan Hospital

About

Zhiyong Peng is an author at Zhongnan Hospital of Wuhan University specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.9K
2	Public Health	3	3	799
3	Engineering	2	2	38
4	Health Sciences	1	1	17
5	Applied Physics	1	1	28

Zhiyong Peng

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Yinghui Jin, Lin Cai, Zhenshun Cheng, Military Medical Research World Health OrganizationViral DiagnosticsStandard VersionHospital RescueRapid Advice Guideline	2020	2.3K
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China Guqin Zhang, Chang Hu, Linjie Luo, Journal of Clinical Virology Virus EpidemiologyCovid-19 PandemicClinical EpidemiologyClinical FeaturesShort-term Outcomes	2020	667
Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2 Yi Peng, Jiling Zhao, Zhiyong Peng, Cell Death and Disease	2020	162
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial George R. Thompson, Àlex Soriano, Oliver A. Cornely, The Lancet Translational MedicineAntifungal AgentAntifungal AgentsRezafungin Versus CaspofunginRandomised Phase 3	2022	150
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial Fang Liu, Yuan Zhu, Jing Zhang, BMJ Open	2020	147
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version) Yinghui Jin, Qingyuan Zhan, Zhiyong Peng, Military Medical Research	2020	121
Downregulation of exosome‐encapsulated miR‐548c‐5p is associated with poor prognosis in colorectal cancer Zhiyong Peng, Runhuan Gu, Bin Yan Journal of Cellular Biochemistry OncologyMedicineExosome‐encapsulated Mir‐548c‐5pCancer Cell BiologyPathology	2018	104
Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China Guqin Zhang, Chang Hu, Linjie Luo, Virus EpidemiologyClinical FeaturesCovid-19 EpidemiologyCovid-19Clinical Epidemiology	2020	91
The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community‐acquired pneumonia Sachin Yende, Derek C. Angus, Lan Kong, The FASEB Journal	2009	87
Downregulation of macrophage migration inhibitory factor attenuates NLRP3 inflammasome mediated pyroptosis in sepsis-induced AKI Tianlong Li, Haibin Sun, Yiming Li, Cell Death Discovery	2022	83

Page 1